Doctor profile · Federal record

Dr. Christopher Barnes, D.O.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Elmira, NY

  • NPI 1982018933
  • Accepts Medicare
  • MIPS 78.1 / 100 · 2023
  • 12 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
600 Roe Ave Ste 1G
Elmira, NY 149051629
(607) 795-2820
fax (607) 795-2821
Mailing address
571 Saint Josephs Blvd, Fl 2
Elmira, NY 149013230

Credentials & registration

NPPES · NUCC
NPI registered
June 2014 — 12 yrs on file
Profile last updated
November 20, 2020
Year of graduation
2014 — 12 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
New York #298004
Medicaid (2)
PA #103729783 · NY #05776921

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1982018933. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
733
Distinct HCPCS
8
Medicare allowed
$70,040
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 372 209 $95
99214 Established patient office or other outpatient visit, 30-39 minutes 220 124 $117
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 48 26 $34
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 31 14 $34
99213 Established patient office or other outpatient visit, 20-29 minutes 21 17 $64
99204 New patient office or other outpatient visit, 45-59 minutes 15 15 $153
99204 New patient office or other outpatient visit, 45-59 minutes 14 14 $125
99203 New patient office or other outpatient visit, 30-44 minutes 12 12 $81

In context: peer comparison

Among 2 peers in this city , average services per provider: 120. This provider delivers 6.1× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$50
Transactions
2
Manufacturers
2
Payer (manufacturer) Industry Txns Amount
Medtronic, Inc. 1 $29.77
Abbott Laboratories 1 $20.07

By nature of payment

Food and Beverage
$50

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,032
Patients
908
Total drug cost
$2,411,356
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 985 206 $14,774
Ozempic (Semaglutide) Brand 603 106 $842,242
Jardiance (Empagliflozin) Brand 366 79 $380,411
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 316 80 $264,520
Metformin Hcl Generic 255 66 $2,262
Trulicity (Dulaglutide) Brand 249 55 $377,200
Metformin Hcl Er (Metformin Hcl) Brand 246 56 $4,494
Farxiga (Dapagliflozin Propanediol) Brand 191 41 $180,626
Glipizide Er (Glipizide) Brand 150 34 $3,726
Novolog Flexpen (Insulin Aspart) Brand 141 48 $186,797

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Christopher Barnes's medical specialty?
Dr. Christopher Barnes practices Endocrinology, Diabetes & Metabolism Physician in Elmira, NY.
Where does Dr. Christopher Barnes practice?
Dr. Christopher Barnes practices at 600 Roe Ave Ste 1G, Elmira, NY 149051629. Office phone: 6077952820.
What is Dr. Christopher Barnes's NPI?
Dr. Christopher Barnes's National Provider Identifier (NPI) is 1982018933, issued by NPPES.
Does Dr. Christopher Barnes accept Medicare assignment?
Yes. Dr. Christopher Barnes accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Barnes commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.